1. Home
  2. MTEM

as 07-26-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

Founded: N/A Country:
United States
United States
Employees: N/A City: AUSTIN
Market Cap: 8.5M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 16.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.14 EPS Growth: N/A
52 Week Low/High: $1.01 - $9.45 Next Earning Date: 08-08-2024
Revenue: $31,763,000 Revenue Growth: -33.68%
Revenue Growth (this year): -78.3% Revenue Growth (next year): -90.52%

MTEM Daily Stock ML Predictions

Stock Insider Trading Activity of Molecular Templates Inc. (MTEM)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
BIOTECH TARGET N V MTEM 10% Owner Apr 2 '24 Buy $2.35 250,000 $587,500.00 1,279,820 SEC Form 4

Share on Social Networks: